Literature DB >> 30306838

Bi-level variable selection for case-cohort studies with group variables.

Soyoung Kim1, Kwang Woo Ahn1.   

Abstract

The case-cohort design is an economical approach to estimate the effect of risk factors on the survival outcome when collecting exposure information or covariates on all patients is expensive in a large cohort study. Variables often have group structure such as categorical variables and highly correlated continuous variables. The existing literature for case-cohort data is limited to identifying non-zero variables at individual level only. In this article, we propose a bi-level variable selection method to select non-zero group and within-group variables for case-cohort data when variables have group structure. The proposed method allows the number of variables to diverge as the sample size increases. The asymptotic properties of the estimator including bi-level variable selection consistency and the asymptotic normality are shown. We also conduct simulations to compare our proposed method with some existing method and apply them to the Busselton Health data.

Entities:  

Keywords:  Case-cohort design; efficiency; multiple diseases; survival analysis; variable selection

Mesh:

Substances:

Year:  2018        PMID: 30306838      PMCID: PMC6748310          DOI: 10.1177/0962280218803654

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  13 in total

1.  Exposure stratified case-cohort designs.

Authors:  O Borgan; B Langholz; S O Samuelsen; L Goldstein; J Pogoda
Journal:  Lifetime Data Anal       Date:  2000-03       Impact factor: 1.588

2.  Group and within-group variable selection for competing risks data.

Authors:  Kwang Woo Ahn; Anjishnu Banerjee; Natasha Sahr; Soyoung Kim
Journal:  Lifetime Data Anal       Date:  2017-08-04       Impact factor: 1.588

3.  Variable selection for multivariate failure time data.

Authors:  Jianwen Cai; Jianqing Fan; Runze Li; Haibo Zhou
Journal:  Biometrika       Date:  2005       Impact factor: 2.445

4.  Marginal hazards model for case-cohort studies with multiple disease outcomes.

Authors:  S Kang; J Cai
Journal:  Biometrika       Date:  2009-12       Impact factor: 2.445

5.  Variable selection for case-cohort studies with failure time outcome.

Authors:  A I Ni; Jianwen Cai; Donglin Zeng
Journal:  Biometrika       Date:  2016-08-10       Impact factor: 2.445

6.  More efficient estimators for case-cohort studies.

Authors:  S Kim; J Cai; W Lu
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

7.  A SIGNIFICANCE TEST FOR THE LASSO.

Authors:  Richard Lockhart; Jonathan Taylor; Ryan J Tibshirani; Robert Tibshirani
Journal:  Ann Stat       Date:  2014-04       Impact factor: 4.028

8.  Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia.

Authors:  M W Knuiman; M L Divitini; J K Olynyk; D J Cullen; H C Bartholomew
Journal:  Am J Epidemiol       Date:  2003-07-15       Impact factor: 4.897

9.  A group bridge approach for variable selection.

Authors:  Jian Huang; Shuange Ma; Huiliang Xie; Cun-Hui Zhang
Journal:  Biometrika       Date:  2009-06       Impact factor: 2.445

10.  Supervised group Lasso with applications to microarray data analysis.

Authors:  Shuangge Ma; Xiao Song; Jian Huang
Journal:  BMC Bioinformatics       Date:  2007-02-22       Impact factor: 3.169

View more
  3 in total

1.  Risk Factor Identification in Heterogeneous Disease Progression with L1-Regularized Multi-state Models.

Authors:  Xuan Dang; Shuai Huang; Xiaoning Qian
Journal:  J Healthc Inform Res       Date:  2021-01-04

2.  Feature screening for case-cohort studies with failure time outcome.

Authors:  Jing Zhang; Haibo Zhou; Yanyan Liu; Jianwen Cai
Journal:  Scand Stat Theory Appl       Date:  2020-11-16       Impact factor: 1.040

3.  Conditional screening for ultrahigh-dimensional survival data in case-cohort studies.

Authors:  Jing Zhang; Haibo Zhou; Yanyan Liu; Jianwen Cai
Journal:  Lifetime Data Anal       Date:  2021-08-20       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.